Last CNY15.89 CNY
Change Today -0.12 / -0.75%
Volume 25.3M
As of 2:05 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

shanghai pharmaceuticals-a (601607) Snapshot

Open
CNY16.01
Previous Close
CNY16.01
Day High
CNY16.02
Day Low
CNY15.52
52 Week High
12/9/14 - CNY16.88
52 Week Low
04/29/14 - CNY11.64
Market Cap
40.9B
Average Volume 10 Days
37.0M
EPS TTM
CNY0.92
Shares Outstanding
1.9B
EX-Date
05/26/14
P/E TM
17.2x
Dividend
CNY0.26
Dividend Yield
1.64%
Current Stock Chart for SHANGHAI PHARMACEUTICALS-A (601607)

Related News

No related news articles were found.

shanghai pharmaceuticals-a (601607) Related Businessweek News

No Related Businessweek News Found

shanghai pharmaceuticals-a (601607) Details

Shanghai Pharmaceuticals Holding Co., Ltd. is engaged in the research and development, manufacture, distribution, and retail of pharmaceutical products in China and internationally. The company offers products ranging from chemical and bio-pharms, modern Chinese medicine, healthcare products, medical devices, etc. in various therapeutic areas, including cardiovascular, systemic anti-infections, digestive system and immune-metabolism, neuropsychiatric, and antineoplastic. The company offers its products in various dosage forms, such as tablets, capsules, powder, mini-volume injections, eye-drops, inhalants, coagulants, etc. It also distributes vaccines and high-end consumables; and provides hospital service solutions focusing on the extended supply chain services, clinical supportive services, logistics, and information technology services. In addition, the company operates a chain of drugstores, pharmacies, joint-venture drugstores, DTP drugstores, etc. It has a strategic alliance with Shanghai Institute of Materia Medica. Shanghai Pharmaceuticals Holding Co., Ltd. was formerly known as Shanghai No. 4 Pharmaceutical Co., Ltd. The company was incorporated in 1994 and is based in Shanghai, China.

39,646 Employees
Last Reported Date: 03/28/14
Founded in 1994

shanghai pharmaceuticals-a (601607) Top Compensated Officers

Chairman, Convener of Strategy Committee and ...
Total Annual Compensation: --
Executive Director
Total Annual Compensation: --
Employee Supervisor
Total Annual Compensation: --
Chairman of the Supervisory Board
Total Annual Compensation: --
Supervisor
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

shanghai pharmaceuticals-a (601607) Key Developments

Shanghai Pharmaceuticals Holding Co., Ltd. Announces Change of Principal Place of Business in Hong Kong with Effect from 1 December 2014

The board of directors of Shanghai Pharmaceuticals Holding Co., Ltd. announced that the principal place of business of the company in Hong Kong has been changed to 36/F, Tower Two, Times Square, 1 Matheson Street, Causeway Bay, Hong Kong with effect from 1 December 2014.

Shanghai Pharmaceuticals Holding Co., Ltd. Announces Unaudited Consolidated and Standalone Earnings Results for Third Quarter and Nine Months Ended Sept. 30, 2014

Shanghai Pharmaceuticals Holding Co., Ltd. announced unaudited consolidated and standalone earnings results for third quarter and nine months ended Sept. 30, 2014. For the quarter, on standalone basis, the company reported revenue of RMB 1,663,329.81, operating loss of RMB 69,144,048.62, total profit of RMB 41,183,688.98, net profit of RMB 41,183,688.98, compared to the revenue of RMB 397,746.62, operating profit of RMB 624,417,752.94, total profit of RMB 624,873,616.61, net profit of RMB 624,873,616.61, for the same quarter a year ago. For the year to date, on standalone basis, the company reported revenue of RMB 4,145,276.08, operating profit of RMB 629,355,606.09, total profit of RMB 750,179,969.69, net profit of RMB 750,179,969.69, net cash used in operating activities of RMB 489,492,581.83, cash paid to acquire fixed assets, intangible assets and other long-term assets of RMB 30,197,582.06 compared to the revenue of RMB 758,512.67, operating profit of RMB 585,857,425.56, total profit of RMB 589,665,535.87, net profit of RMB 614,949,865.4, net cash flows from operating activities of RMB 79,349,300.85, cash paid to acquire fixed assets, intangible assets and other long-term assets of RMB 13,378,092.22 for the same period a year ago. For the quarter, on consolidated basis, the company reported total revenue of RMB 24,702,971,084, operating profit of RMB 749,575,379.79, total profit of RMB 877,478,437.1, net profit of RMB 699,413,705.33 or RMB 0.2211 compared to the total revenue of RMB 19,339,735,450.36, operating profit of RMB 715,111,539.74, total profit of RMB 744,575,417.68, net profit of RMB 583,500,365.22 or RMB 0.1815 for the same quarter a year ago. For the year to date, on consolidated basis, the company reported total revenue of RMB 68,715,987,409.43, operating profit of RMB 2,605,904,806.6, total profit of RMB 2,794,581,300.88, net profit of RMB 2,214,054,980.04 or RMB 0.7113 net cash flows from operating activities of RMB 740,485,653.27, cash paid to acquire fixed assets, intangible assets and other long-term assets of RMB 651,252,476.74 compared to the total revenue of RMB 58,057,637,248.5, operating profit of RMB 2,330,603,631.01, total profit of RMB 2,419,174,281.07, net profit of RMB 1,951,795,807.96 or RMB 0.6132 net cash flows from operating activities of RMB 552,947,678.42, cash paid to acquire fixed assets, intangible assets and other long-term assets of RMB 605,006,218.32 for the same period a year ago. Weighted average returns on net assets was 7.21%.

Shanghai Pharmaceuticals Holding Co., Ltd., Special/Extraordinary Shareholders Meeting, Dec 16, 2014

Shanghai Pharmaceuticals Holding Co., Ltd., Special/Extraordinary Shareholders Meeting, Dec 16, 2014., at 14:30 China Standard Time. Location: Ocean Energy Hall, 1st Floor, Shanghai Science Hall. Agenda: To consider election of Mr. HE Chuan as a supervisor of the Company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY15.89 CNY -0.12

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY52.58 CNY -1.61
Jointown Pharmaceutical Group Co Ltd CNY20.18 CNY -0.57
Nanjing Pharmaceutical Co Ltd CNY7.40 CNY -0.16
Wanjia Group Holdings Ltd $0.45 HKD +0.015
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 16.8x
Price/Sales 0.5x
Price/Book 1.6x
Price/Cash Flow 12.0x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI PHARMACEUTICALS-A, please visit www.pharm-sh.com.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.